Remus Pharmaceuticals Limited (NSE:REMUS)

Remus Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 11, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	9,669	13,192	10,163	-	-	-
Market Cap Growth	29.81%	29.81%	-	-	-	-
Enterprise Value	10,085	13,164	10,212	-	-	-
Last Close Price	820.55	1119.47	861.57	-	-	-
PE Ratio	25.17	45.38	47.19	-	-	-
PS Ratio	1.56	2.13	4.77	-	-	-
PB Ratio	3.42	4.67	9.74	-	-	-
P/TBV Ratio	3.92	5.34	13.11	-	-	-
P/FCF Ratio	-	-	342.57	-	-	-
P/OCF Ratio	138.53	189.00	282.11	-	-	-
EV/Sales Ratio	1.63	2.12	4.80	-	-	-
EV/EBITDA Ratio	22.07	28.81	35.41	-	-	-
EV/EBIT Ratio	23.01	30.04	36.52	-	-	-
EV/FCF Ratio	-243.59	-	344.23	-	-	-
Debt / Equity Ratio	0.08	0.08	0.11	0.42	0.03	0.09
Debt / EBITDA Ratio	0.50	0.50	0.40	0.71	0.04	0.21
Debt / FCF Ratio	-	-	3.89	3.08	0.04	0.10
Asset Turnover	1.80	1.80	1.46	1.79	1.84	2.30
Inventory Turnover	11.29	11.29	7.62	22.88	8.96	14.50
Quick Ratio	0.96	0.96	0.96	0.97	0.44	0.58
Current Ratio	1.82	1.82	1.40	1.39	0.84	0.98
Return on Equity (ROE)	19.86%	19.86%	42.08%	66.14%	71.37%	40.49%
Return on Assets (ROA)	7.94%	7.94%	11.97%	26.40%	19.63%	8.89%
Return on Capital (ROIC)	13.00%	13.00%	24.45%	39.41%	52.34%	25.48%
Return on Capital Employed (ROCE)	14.10%	14.10%	25.90%	40.30%	63.30%	34.60%
Earnings Yield	3.01%	2.20%	2.12%	-	-	-
FCF Yield	-0.43%	-0.31%	0.29%	-	-	-
Dividend Yield	0.09%	0.07%	0.09%	-	-	-
Payout Ratio	4.06%	4.06%	2.74%	-	-	-
Buyback Yield / Dilution	21.35%	21.35%	-38.79%	-2.10%	-	-
Total Shareholder Return	21.44%	21.42%	-38.70%	-2.10%	-	-

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.